1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
68745D6A27532BD3E85256E860068C250
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/winning-the-hearts-and-minds-of-preferred-clinical-investigators?opendocument
18
19opendocument
2034.204.173.45
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Clinical Operations Clinical Trial Investigators

Winning the Hearts and Minds of Preferred Clinical Investigators

DB Image

ID: 4620


Features:

Metrics, Graphics


Pages/Slides: 29


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

Attracting preferred investigators and winning their participation in clinical trials requires careful planning and execution by study sponsors. CRO and pharmaceutical executives must preserve and promote relationships with investigators to efficiently acquire high quality data during a study. This 32-page document will help pharmaceutical and CRO executives better position their studies to recruit top investigators and keep those investigators loyal.

Key Topics

  • relationship management
  • protocol involvement
  • services and training.

Sample Best Practices
1.Supply customized patient recruitment support to increase investigator satisfaction and meet enrollment targets.
-For example, one investigator stated that the ideal relationship is to have a national patient recruitment organization do advertisements with a screening questionnaire before a site takes the resulting referrals.
2.Create a two-tiered process for protocol review to ensure protocols are designed for both scientific value and ease of completion.
- One benchmark partner’s clinical science group may bring KOLs in for an advisory board meeting to draft a protocol from the very beginning. After the draft protocol is in place, regional managers then bring it to about six key investigators seeking insight on potential challenges to patient enrollment.
3. Provide study coordinators with training and opportunities to participate in advisory boards to win their loyalty to clinical trials.
-One company uses meetings, symposia and other such tactics to acknowledge the contributions that study coordinators make.

Methodology

This research originated from a Best Practices, LLC consulting project. It was conducted for a pharmaceutical client and was based on interviews and surveys with pharmaceutical, CRO and investigative site benchmark partners.


Industries Profiled:
Pharmaceutical; Research; Biotech


Companies Profiled:
AAI Development; Amgen; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; Covance; Lilly; GlaxoSmithKline

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.